Singapore Medical Group (SMG) has reported 36.1% lower earnings of $8.7 million for the FY2020 ended December, from earnings of $13.7 million in the year before.

FY2020 group revenue fell 7.7% y-o-y to $87.3 million due to lower revenue from its Diagnostic & Aesthetics Business and Health Business segments.

The lower revenue from both segments were attributable to lower patient volumes from the deferment of non-essential medical services and the temporary closure of certain clinics during the circuit breaker period from April to June 2020.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook